Gemcitabine in Treating Patients With Newly Diagnosed, Relapsed, or Chemotherapy-Resistant Mantle Cell Lymphoma
Clinical trial NCT00234026 · COMPLETED
Trial details
- NCT number
- NCT00234026
- Sponsor
- Swiss Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2006-03-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.